StockNews.AI
GRDN
StockNews.AI
146 days

Guardian Pharmacy Services, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results

1. GRDN reports 20% revenue growth in Q4 2024, driven by acquisitions. 2. Acquisition of Heartland Pharmacy contributes positively to financial performance.

Earnings
+4.04%Current Return
VS
-0.28%S&P 500
$20.2903/26 04:14 PM EDTEvent Start
$21.1103/27 11:00 PM EDTLatest Updated
2m saved
Insight
Article

FAQ

Why Bullish?

The 20% revenue increase suggests strong demand and effective growth strategies, similar to prior successful quarters, which often led to positive stock reactions in similar pharmacy service companies.

How important is it?

The significant revenue growth and positive outlook from acquisitions typically attract investor attention, reinforcing GRDN’s market position and promising stability.

Why Short Term?

Immediate market reactions can occur due to strong financial results, with investor sentiment likely to improve in the near term, similar to past trends observed post-earnings releases.

Related Companies

ABTCVSWBA
ATLANTA--(BUSINESS WIRE)--Guardian Pharmacy Services, Inc. (“Guardian”) (NYSE: GRDN), one of the nation's largest long-term care (LTC) pharmacy services companies, today announced financial results for the fourth quarter and full year ended December 31, 2024. Fourth Quarter and Full Year Highlights Three Months Ended December 31, 2024 Revenue of $338.6 million, an increase of 20% year-over-year, driven by organic growth and the previously announced acquisitions of Heartland Pharmacy on April 1,.

Related News